Mineralocorticoid and AT1 receptors in the paraventricular nucleus contribute to sympathetic hyperactivity and cardiac dysfunction in rats post myocardial infarct

Journal of Physiology

Volumn 592, Issue 15, 2014, Pages 3273-3286

  Huang, Bing S ^a   Chen, Aidong ^a   Ahmad, Monir ^a   Wang, Hong Wei ^a   Leenen, Frans H H ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; METOPROLOL; MINERALOCORTICOID RECEPTOR; PARVOVIRUS VECTOR; SMALL INTERFERING RNA; ANGIOTENSIN 1 RECEPTOR ANTAGONIST;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; DESENSITIZATION; DRUG EFFECT; DRUG MECHANISM; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PEAK SYSTOLIC PRESSURE; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; KIDNEY INNERVATION; LOW DRUG DOSE; MALE; MECHANICAL STRESS; NERVE POTENTIAL; NONHUMAN; PATHOPHYSIOLOGY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SYMPATHETIC TONE; SYSTEMIC THERAPY; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; ADRENERGIC SYSTEM; ANIMAL; GENETICS; HEART INFARCTION; HEART VENTRICLE FUNCTION; METABOLISM; UPREGULATION; WISTAR RAT;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BAROREFLEX; MALE; METOPROLOL; MYOCARDIAL INFARCTION; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, MINERALOCORTICOID; SYMPATHETIC NERVOUS SYSTEM; UP-REGULATION; VENTRICULAR DYSFUNCTION;

EID: 84905215433     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2014.276584     Document Type: Article

References (41)

1. Ahmad M, White R, Tan J, Huang BS & Leenen FHH (2008). Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction. J Cardiovasc Pharmacol 51, 565-572.
2. Bristow MR (2011). Treatment of chronic heart failure with β-adrenergic receptor antagonists: a convergence of receptor pharmacology and clinical cardiology. Circ Res 109, 1176-1194.
3. Capone C, Faraco G, Peterson JR, Coleman C, Anrather J, Milner TA, Pickel VM, Davisson RL & Iadecola C (2012). Central cardiovascular circuits contribute to the neurovascular dysfunction in angiotensin II hypertension. J Neurosci 32, 4878-4886.
4. Chen A, Huang BS, Wang H-W, Ahmad M & Leenen FHH (2014). Knockdown of mineralocorticoid or angiotensin II type 1 receptor gene expression in the paraventricular nucleus prevents angiotensin II hypertension in rats. J Physiol (in press) Doi:10.1113/jphysiol.2014.275560.
5. DiBona GF, Jones SY & Brooks VL (1995). ANG II receptor blockade and arterial baroreflex regulation of renal nerve activity in cardiac failure. Am J Physiol Regul Integr Comp Physiol 269, R1189-R1196.
6. Francis J, Weiss RM, Wei SG, Johnson AK, Beltz TG, Zimmerman K & Felder RB (2001). Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. Am J Physiol Heart Circ Physiol 281, H2241-H2251.
7. Füchtbauer L, Groth-Rasmussen M, Holm TH, Løbner M, Toft-Hansen H, Khorooshi R & Owens T (2011). Angiotensin II Type 1 receptor (AT1) signaling in astrocytes regulates synaptic degeneration-induced leukocyte entry to the central nervous system. Brain Behav Immun 25, 897-904.
8. 1 receptor blockade. J Mol Cell Cardiol 43, 479-486.
9. 1 receptors and cardiac dysfunction in rats post-myocardial infarction. Am J Physiol Heart Circ Physiol 297, H968-H975.
10. Huang BS, White RA, Ahmad M, Tan J, Jeng AY & Leenen FHH (2009b). Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodeling in rats after myocardial infarction. Cardiovasc Res 81, 574-781.
11. Huang BS, Zheng H, Tan J, Patel KP & Leenen FHH (2011). Regulation of hypothalamic renin-angiotensin system and oxidative stress by aldosterone. Exp Physiol 96, 1028-1038.
12. Infanger DW, Cao X, Butler SD, Burmeister MA, Zhou Y, Stupinski JA, Sharma RV & Davisson RL (2010). Silencing nox4 in the paraventricular nucleus improves myocardial infarction-induced cardiac dysfunction by attenuating sympathoexcitation and periinfarct apoptosis. Circ Res 106, 1763-1774.
13. Keen-Rhinehart E, Kalra SP & Kalra PS (2005). AAV-mediated leptin receptor installation improves energy balance and the reproductive status of obese female Koletsky rats. Peptides 26, 2567-2578.
14. Kolettis TM, Barton M, Langleben D & Matsumura Y (2013). Endothelin in coronary artery disease and myocardial infarction. Cardiol Rev 21, 249-256.
15. Lal A, Veinot JP, Ganten D & Leenen FHH (2005). Prevention of cardiac remodeling after myocardial infarction in transgenic rats deficient in brain angiotensinogen. J Mol Cell Cardiol 39, 521-529.
16. Lal A, Veinot JP & Leenen FHH (2004). Critical role of CNS effects of aldosterone in cardiac remodeling post-myocardial infarction in rats. Cardiovasc Res 64, 437-447.
17. Latini R, Masson S, Jeremic G, Luvarà G, Fiordaliso F, Calvillo L, Bernasconi R, Torri M, Rondelli I, Razzetti R & Bongrani S (1998). Comparative efficacy of a DA2/α2 agonist and a β-blocker in reducing adrenergic drive and cardiac fibrosis in an experimental model of left ventricular dysfunction after coronary artery occlusion. J Cardiovasc Pharmacol 31, 601-608.
18. Leenen FHH (2007). Brain mechanisms contributing to sympathetic hyperactivity and heart failure. Circ Res 101, 221-223.
19. Leenen FHH, Skarda V, Yuan B & White R (1999). Changes in cardiac ANG II postmyocardial infarction in rats: effects of nephrectomy and ACE inhibitors. Am J Physiol Heart Circ Physiol 276, H317-H325.
20. Litwin SE, Katz SE, Morgan JP & Douglas PS (1999). Effects of propranolol treatment on left ventricular function and intracellular calcium regulation in rats with postinfarction heart failure. Br J Pharmacol 127, 1671-1679.
21. Liu D, Gao L, Roy SK, Cornish KG & Zucker IH (2006). Neuronal angiotensin II type 1 receptor upregulation in heart failure: activation of activator protein 1 and Jun N-terminal kinase. Circ Res 99, 1004-1011.
22. 2+ handling in the post-infarction rat heart. Cardiovasc Res 79, 42-51.
23. 1) expressing neurones in the hypothalamic paraventricular nucleus of the rat. J Neuroendocrinol 13, 139-146.
24. 1-blockade attenuates post-infarct remodelling without improvement in myocardial energy metabolism and function in rats with heart failure. Eur J Heart Fail 5, 725-732.
25. Oshima N, Onimaru H, Takechi H, Yamamoto K, Watanabe A, Uchida T, Nishida Y, Oda T & Kumagai H (2013). Aldosterone is synthesized in and activates bulbospinal neurons through mineralocorticoid receptors and ENaCs in the RVLM. Hypertens Res 36, 504-512.
26. Patel KP & Zhang K (1996). Neurohumoral activation in heart failure: role of paraventricular nucleus. Clin Exp Pharmacol Physiol 23, 722-726.
27. 1 receptor and ACE densities after myocardial infarct in rats. Am J Physiol Heart Circ Physiol 286, H1665-H1671.
28. + sodium channels in magnocellular cells of the rat supraoptic and paraventricular nuclei. Am J Physiol Endocrinol Metab 302, E273-E285.
29. Vahid-Ansari F & Leenen FHH (1998). Pattern of neuronal activation in rats with CHF after myocardial infarction. Am J Physiol Heart Circ Physiol 275, H2140-H2146.
30. 1aR) by RNA interference. Hypertension 45, 115-119.
31. Wang H, Huang BS, Ganten D & Leenen FHH (2004). Prevention of sympathetic and cardiac dysfunction after myocardial infarction in transgenic rats deficient in brain angiotensinogen. Circ Res 94, 843-849.
32. Wang HW, Amin MS, El-Shahat E, Huang BS, Tuana BS & Leenen FHH (2010). Effects of central sodium on epithelial sodium channels in rat brain. Am J Physiol Regul Integr Comp Physiol 299, R222-R233.
33. Wang X, Skelley L, Cade R & Sun Z (2006). AAV delivery of mineralocorticoid receptor shRNA prevents progression of cold-induced hypertension and attenuates renal damage. Gene Ther 13, 1097-1103.
34. Wei S, Chow LT & Sanderson JE (2000). Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction. J Am Coll Cardiol 36, 276-281.
35. 1 receptor expression in rats via the mitogen-activated protein kinase pathway. Am J Physiol Heart Circ Physiol 296, H1425-H1433.
36. Wei SG, Yu Y, Zhang ZH, Weiss RM & Felder RB (2008). Mitogen-activated protein kinases mediate upregulation of hypothalamic angiotensin II type 1 receptors in heart failure rats. Hypertension 52, 679-686.
37. 2-Adrenergic stimulation attenuates left ventricular remodeling, decreases apoptosis, and improves calcium homeostasis in a rodent model of ischemic cardiomyopathy. J Pharmacol Exp Ther 317, 553-561.
38. Yu Y, Wei SG, Zhang ZH, Gomez-Sanchez E, Weiss RM & Felder RB (2008). Does aldosterone upregulate the brain renin-angiotensin system in rats with heart failure? Hypertension 51, 727-733.
39. Yu Y, Zhang ZH, Wei SG, Weiss RM & Felder RB (2012). Peroxisome proliferator-activated receptor-γ regulates inflammation and renin-angiotensin system activity in the hypothalamic paraventricular nucleus and ameliorates peripheral manifestations of heart failure. Hypertension 59, 477-484.
40. Zhang ZH, Francis J, Weiss RM & Felder RB (2002). The renin-angiotensin-aldosterone system excites hypothalamic paraventricular nucleus neurons in heart failure. Am J Physiol Heart Circ Physiol 283, H423-H433.
41. Zheng H, Li YF, Wang W & Patel KP (2009). Enhanced angiotensin-mediated excitation of renal sympathetic nerve activity within the paraventricular nucleus of anesthetized rats with heart failure. Am J Physiol Regul Integr Comp Physiol 297, R1364-R1374.